Bioharvest Sciences Inc (BHST) Stock Price, Quote & News

Company Profile

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and function...

Industry: Packaged Foods

Sector: Consumer Defensive

Phone: 604 689 5722

Fax: 604 685 9182

Website: www.bioharvest.com

Address:

1140-625 Howe Street, Vancouver, Canada

focafoca99 May. 28 at 3:13 PM

$BHST called a shareholder meeting for May 2026, filing a proxy notice and information circular.

1 · Reply

sepsis74 May. 22 at 5:08 PM

$BHST so.... looks like the market really didn't like the CEO change. The stocks been falling in much heavier volume than normal.

0 · Reply

forgottenchuck May. 18 at 8:50 PM

$BHST look at the price jump on tate and lyle stock on news of buyout. keep a eye out on bioharvest on potential buyout news

1 · Reply

forgottenchuck May. 18 at 8:41 PM

$BHST this news is going to blow peoples mind. bioharvest up next

0 · Reply

forgottenchuck May. 18 at 7:49 PM

$BHST look for tate and lyle to buyout bioharvest

0 · Reply

BioHarvest_Sciences May. 18 at 11:40 AM

$BHST News Release--> TATE & LYLE EXPANDS COLLABORATION WITH BIOHARVEST SCIENCES TO ACCELERATE NEXT-GENERATION SWEETENER INNOVATION Expanded sweetener molecule development program aims to broaden access to plant based sweetening solutions tailored to diverse customer food and beverage categories. Read Full Release: https://ir.bioharvest.com/news/default.aspx

0 · Reply

newsfile_corp May. 18 at 11:00 AM

https://nfne.ws/297782 $BHST @BioHarvestBHSC #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals #NASDAQ #Investing

0 · Reply

TheJuan May. 14 at 8:59 PM

$BHST Can someone buy 10% so they can tell management to sell Vinia in a structure similar to how they are doing CDMO. Cut expenses related to marketing, focus up on capacity expansion, partneship building, and debt reduction. This co is so close to being investable.

0 · Reply

focafoca99 May. 14 at 5:16 PM

$BHST registered unaudited interim financial statements for the quarter ended March 31, 2026.

0 · Reply

MarketBeat May. 14 at 2:09 PM

https://marketbeat.com/a/8654651/ $BHST BioHarvest Sciences Q1 Earnings Call Highlights

0 · Reply

Tate & Lyle Expands Collaboration with BioHarvest Sciences to Accelerate Next-Generation Sweetener Innovation

May 14, 2026, 8:00 AM EDT - 21 days ago

BioHarvest Sciences Earnings Call Transcript: Q1 2026

May 14, 2026, 8:00 AM EDT - 21 days ago

BioHarvest Sciences Earnings release: Q1 2026

May 14, 2026, 8:00 AM EDT - 21 days ago

BioHarvest Sciences Earnings release: Q1 2026

May 14, 2026, 7:00 AM EDT - 21 days ago

BioHarvest Sciences Reports First Quarter 2026 Financial Results and Provides Business Update

May 13, 2026, 5:32 PM EDT - 22 days ago

BioHarvest Sciences Appoints New Head of Business Development for its CDMO Division

May 13, 2026, 8:00 AM EDT - 22 days ago

BioHarvest Sciences Announces Successful Completion of Stage 1 Development of Saffron Composition for Nutraceutical and Culinary Applications

May 12, 2026, 7:30 AM EDT - 23 days ago

BioHarvest Sciences Signs $1.2M CDMO Stage 2 Contract for the Development of a Rare Fragrance Using Its Proprietary Botanical Synthesis Platform

May 1, 2026, 7:00 AM EDT - 4 weeks ago

BioHarvest Sciences Slides: Corporate presentation

Apr 30, 2026, 4:05 PM EDT - 5 weeks ago

BioHarvest Sciences to Report First Quarter 2026 Financial Results on May 14, 2026

Apr 29, 2026, 8:30 AM EDT - 5 weeks ago

BioHarvest Sciences Announces Strategic Leadership Transition with Dr. Zaki Rakib Assuming Role of Chief Executive Officer to Accelerate "Two-Lens" Growth Strategy

Apr 1, 2026, 7:00 AM EDT - 2 months ago

BioHarvest Sciences Slides: Corporate presentation

Mar 31, 2026, 4:30 PM EDT - 2 months ago

BioHarvest Sciences Earnings Call Transcript: Q4 2025

Mar 31, 2026, 4:30 PM EDT - 2 months ago

BioHarvest Sciences Earnings release: Q4 2025

Mar 31, 2026, 4:30 PM EDT - 2 months ago

BioHarvest Sciences Annual report: Q4 2025

Mar 31, 2026, 4:02 PM EDT - 2 months ago

BioHarvest Sciences Reports Fourth Quarter and Full-Year 2025 Financial Results

Mar 31, 2026, 8:00 AM EDT - 2 months ago

BioHarvest Sciences Announces First-Ever Successful Stable Cell Culture Development of Rare Fragrance-Producing Plant Using Proprietary Botanical Synthesis Platform

Mar 26, 2026, 7:30 AM EDT - 2 months ago

BioHarvest Sciences Announces that VINIA is Now the No.1 Resveratrol Polyphenol Brand in the United States

Mar 17, 2026, 8:30 AM EDT - 2 months ago

BioHarvest Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on March 31, 2026

Mar 13, 2026, 4:53 PM EDT - 2 months ago

BioHarvest Sciences Announces Grant of Long-Term Incentive Awards to Employees, Officers and Directors

Mar 5, 2026, 7:30 AM EST - 3 months ago

BioHarvest Sciences Announces Board Transition and Appointment of Prof. Hezi Levy

Mar 3, 2026, 8:30 AM EST - 3 months ago

BioHarvest Sciences to Participate in 38th Annual Roth Conference on March 22-24, 2026

2026-02-19T09:55:30.000Z - 3 months ago

BioHarvest Sciences initiated with a Buy at Roth Capital

Jan 7, 2026, 7:30 AM EST - 5 months ago

BioHarvest Sciences Issues Year End Shareholder Letter

Dec 18, 2025, 7:30 AM EST - 6 months ago

BioHarvest Sciences Awarded $1.6 Million USD Grant from the Israeli Innovation Authority to Advance Second-Generation Botanical Synthesis Platform

Dec 3, 2025, 7:30 AM EST - 6 months ago

BioHarvest Sciences Announces Launch of VINIA Blood Flow Hydration Product

Nov 13, 2025, 4:30 PM EST - 7 months ago

BioHarvest Sciences Earnings Call Transcript: Q3 2025

Nov 13, 2025, 4:30 PM EST - 7 months ago

BioHarvest Sciences Earnings release: Q3 2025

Nov 13, 2025, 4:05 PM EST - 7 months ago

BioHarvest Sciences Reports Third Quarter 2025 Financial Results

Nov 12, 2025, 8:42 AM EST - 7 months ago

BioHarvest Sciences to Attend the Craig-Hallum 16th Annual Alpha Select Conference on November 18, 2025

Nov 10, 2025, 4:18 PM EST - 7 months ago

BioHarvest Sciences Announces Closing of $19.9 Million Upsized Public Offering of Common Stock and Exercise of Underwriter's Option to Purchase Additional Shares

2025-11-07T12:56:34.000Z - 7 months ago

BioHarvest Sciences 2.485M share Spot Secondary priced at $7.00

Nov 7, 2025, 7:30 AM EST - 7 months ago

BioHarvest Sciences Announces Pricing of $17.4 Million Upsized Public Offering of Common Stock

2025-11-06T22:01:29.000Z - 7 months ago

BioHarvest Sciences files common shares offering, no amount given

Nov 6, 2025, 4:37 PM EST - 7 months ago

BioHarvest Announces Proposed Public Offering of Common Stock

Nov 4, 2025, 7:30 AM EST - 7 months ago

BioHarvest Sciences to Host Third Quarter Earnings Call on November 13 at 4:30 p.m. Eastern Time

Oct 30, 2025, 7:30 AM EDT - 7 months ago

BioHarvest Sciences Announces Strategic CDMO Partnership to Revolutionize Saffron Compound Production with Botanical Synthesis

Sep 22, 2025, 6:32 AM EDT - 9 months ago

BioHarvest Sciences Strengthens Balance Sheet by $14.7 Million with Injection of $10.9 Million Gross Proceeds and Additional $3.8 Million in Debt Reduction

Sep 10, 2025, 1:00 PM EDT - 9 months ago

BioHarvest Sciences Transcript: Status Update

Sep 10, 2025, 1:00 PM EDT - 9 months ago

BioHarvest Sciences Press release: Status Update

2025-09-10T13:40:45.000Z - 9 months ago

BioHarvest Sciences Inc. – Common Stock trading resumes

2025-09-10T13:35:33.000Z - 9 months ago

BioHarvest Sciences Inc. – Common Stock trading halted, volatility trading pause

Sep 10, 2025, 7:00 AM EDT - 9 months ago

BioHarvest Sciences Announces Breakthrough in Botanical Synthesis Capabilities with Plant-Based Exosome Production at Scale

Sep 4, 2025, 7:00 AM EDT - 9 months ago

BioHarvest Sciences Slides: Investor Presentation

Sep 2, 2025, 8:30 AM EDT - 9 months ago

BioHarvest Sciences to Host a Virtual Investor Webinar on September 10, 2025 at 1:00 PM ET

Aug 28, 2025, 8:00 AM EDT - 10 months ago

BioHarvest Sciences Registration statement: Registration Filing

Aug 12, 2025, 11:00 AM EDT - 10 months ago

BioHarvest Sciences Transcript: Canaccord Genuity’s 45th Annual Growth Conference

Aug 11, 2025, 8:00 AM EDT - 10 months ago

BioHarvest Sciences Earnings Call Transcript: Q2 2025

Aug 11, 2025, 8:00 AM EDT - 10 months ago

BioHarvest Sciences Earnings release: Q2 2025

Aug 11, 2025, 7:30 AM EDT - 10 months ago

BioHarvest Sciences Reports Second Quarter 2025 Financial Results

2025-08-06T15:30:16.000Z - 10 months ago

BioHarvest Sciences management to meet with Craig-Hallum

Aug 4, 2025, 8:30 AM EDT - 10 months ago

BioHarvest Sciences to Host Second Quarter 2025 Earnings Call on August 11 at 8:00 a.m. Eastern Time

Jul 23, 2025, 8:30 AM EDT - 11 months ago

BioHarvest Sciences to Present at Canaccord Genuity 45th Annual Growth Conference on August 12-14, 2025

Jun 4, 2025, 7:00 AM EDT - 1 year ago

BioHarvest Launches Informed Sport-Certified VINIA DailyChews 2X Formula for Athletes and People with Active Lifestyles

May 21, 2025, 8:30 AM EDT - 1 year ago

BioHarvest Secures New CDMO Contract to Develop Plant-based Fragrance Compound

May 15, 2025, 4:30 PM EDT - 1 year ago

BioHarvest Sciences Earnings Call Transcript: Q1 2025

May 15, 2025, 4:30 PM EDT - 1 year ago

BioHarvest Sciences Earnings release: Q1 2025

May 15, 2025, 4:05 PM EDT - 1 year ago

BioHarvest Sciences Reports First Quarter 2025 Financial Results

May 12, 2025, 8:30 AM EDT - 1 year ago

BioHarvest Announces Completion of Stage 1 Development for CDMO Contract with Nasdaq-Listed Pharmaceutical Company

2025-05-07T15:40:53.000Z - 1 year ago

BioHarvest Sciences management to meet with Craig-Hallum

2025-05-05T12:31:25.000Z - 1 year ago

Craig-Hallum bullish on BioHarvest Sciences, initiates with a Buy

2025-05-05T11:41:22.000Z - 1 year ago

BioHarvest Sciences initiated with a Buy at Craig-Hallum

May 1, 2025, 8:30 AM EDT - 1 year ago

BioHarvest Sciences to Host First Quarter 2025 Earnings Call on May 15 at 4:30 p.m. Eastern Time

2025-04-25T20:25:52.000Z - 1 year ago

BioHarvest Sciences participates in a conference call with Maxim Group

Mar 31, 2025, 4:30 PM EDT - 1 year ago

BioHarvest Sciences Earnings Call Transcript: Q4 2024

Mar 31, 2025, 4:30 PM EDT - 1 year ago

BioHarvest Sciences Earnings release: Q4 2024

Mar 31, 2025, 4:30 PM EDT - 1 year ago

BioHarvest Sciences Annual report: Q4 2024

Mar 31, 2025, 4:30 PM EDT - 1 year ago

BioHarvest Sciences Earnings release: Q4 2024

Mar 31, 2025, 4:05 PM EDT - 1 year ago

BioHarvest Sciences Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 17, 2025, 8:30 AM EDT - 1 year ago

BioHarvest Sciences to Host Fourth Quarter and Full Year 2024 Earnings Call on March 31 at 4:30 p.m. Eastern Time

Mar 6, 2025, 8:30 AM EST - 1 year ago

BioHarvest Sciences to Participate in 37th Annual Roth Conference on March 16-18, 2025

Mar 4, 2025, 8:30 AM EST - 1 year ago

BioHarvest In Vitro Testing Shows Proprietary Olive Cell Compound Reduces Fat Accumulation in Liver Cells

Feb 18, 2025, 8:30 AM EST - 1 year ago

BioHarvest Announces Sales of Flagship Product VINIA Now Exceed $50 Million USD

Feb 12, 2025, 8:30 AM EST - 1 year ago

BioHarvest Sciences to Present at WeBull Consumer Stocks Webinar on February 18

Jan 22, 2025, 8:30 AM EST - 1 year ago

BioHarvest Announces Appointment of Sharon Malka to Board of Directors

Jan 8, 2025, 8:41 AM EST - 1 year ago

BioHarvest Issues Shareholder Letter and Provides Corporate Update

Dec 11, 2024, 6:00 AM EST - 1 year ago

Tate & Lyle and BioHarvest Announce Partnership to Drive the Future of Ingredients Through Botanical Synthesis Technology

Nov 25, 2024, 4:30 PM EST - 1 year ago

BioHarvest Sciences Earnings Call Transcript: Q3 2024

Nov 25, 2024, 4:30 PM EST - 1 year ago

BioHarvest Sciences Earnings release: Q3 2024

Nov 25, 2024, 4:05 PM EST - 1 year ago

BioHarvest Sciences Reports Third Quarter 2024 Financial Results

Nov 25, 2024, 8:30 AM EST - 1 year ago

BioHarvest Launches VINIA SuperFood Functional Tea Line

Nov 21, 2024, 8:30 AM EST - 1 year ago

BioHarvest Sciences to Participate in Noble Capital Markets Emerging Growth Conference on December 3, 2024

Nov 18, 2024, 8:30 AM EST - 1 year ago

BioHarvest Sciences to Host Third Quarter 2024 Earnings Call on November 25 at 4:30 P.M. Eastern Time

Nov 12, 2024, 8:30 AM EST - 1 year ago

BioHarvest Sciences Begins Trading on the Nasdaq Global Market

Nov 7, 2024, 8:30 AM EST - 1 year ago

BioHarvest Sciences Announces Uplisting to the Nasdaq Global Market

focafoca99 May. 28 at 3:13 PM

$BHST called a shareholder meeting for May 2026, filing a proxy notice and information circular.

1 · Reply

sepsis74 May. 22 at 5:08 PM

$BHST so.... looks like the market really didn't like the CEO change. The stocks been falling in much heavier volume than normal.

0 · Reply

forgottenchuck May. 18 at 8:50 PM

$BHST look at the price jump on tate and lyle stock on news of buyout. keep a eye out on bioharvest on potential buyout news

1 · Reply

forgottenchuck May. 18 at 8:41 PM

$BHST this news is going to blow peoples mind. bioharvest up next

0 · Reply

forgottenchuck May. 18 at 7:49 PM

$BHST look for tate and lyle to buyout bioharvest

0 · Reply

BioHarvest_Sciences May. 18 at 11:40 AM

0 · Reply

newsfile_corp May. 18 at 11:00 AM

https://nfne.ws/297782 $BHST @BioHarvestBHSC #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals #NASDAQ #Investing

0 · Reply

TheJuan May. 14 at 8:59 PM

0 · Reply

focafoca99 May. 14 at 5:16 PM

$BHST registered unaudited interim financial statements for the quarter ended March 31, 2026.

0 · Reply

MarketBeat May. 14 at 2:09 PM

https://marketbeat.com/a/8654651/ $BHST BioHarvest Sciences Q1 Earnings Call Highlights

0 · Reply

EarningsInsider May. 14 at 1:30 PM

https://www.marketbeat.com/earnings/reports/2026-5-14-bioharvest-sciences-inc-stock/ $BHST BioHarvest Sciences Earnings Transcript

0 · Reply

StocktwitsEarnings May. 14 at 1:11 PM

$BHST Q1 '26 Earnings Results & Recap BioHarvest Sciences Inc. maintains its annual revenue guidance range at $42M to $48M, reflecting the company's outlook for the upcoming fiscal year.

0 · Reply

mikesterz7 May. 14 at 11:59 AM

$BHST 🔥🔥🔥

0 · Reply

BioHarvest_Sciences May. 14 at 11:56 AM

$BHST News Release--> BioHarvest Sciences Reports First Quarter 2026 Financial Results and Provides Business Update. Read Full Release: https://ir.bioharvest.com/news/default.aspx

0 · Reply

newsfile_corp May. 14 at 11:01 AM

https://nfne.ws/297459 $BHST @BioHarvestBHSC #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals #Earnings #QuarterlyResult

0 · Reply

newsfile_corp May. 13 at 9:33 PM

https://nfne.ws/297382 $BHST @BioHarvestBHSC #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals #Appointment #NASDAQ #Inve

0 · Reply

BioHarvest_Sciences May. 13 at 4:05 PM

$BHST News Release--> BioHarvest Sciences Announces Successful Completion of Stage 1 Development of Saffron Composition for Nutraceutical and Culinary Applications. CDMO program now advances to Stage 2 of ongoing development agreement. Read Full Release: https://ir.bioharvest.com/news/default.aspx

0 · Reply

focafoca99 May. 13 at 12:19 PM

$BHST achieved a milestone as it completed Stage 1 of its saffron cell‑bank development, moving the program toward Stage 2.

0 · Reply

newsfile_corp May. 13 at 12:01 PM

https://nfne.ws/297297 $BHST @BioHarvestBHSC #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals #NASDAQ #Investing

0 · Reply

BioHarvest_Sciences May. 12 at 2:13 PM

$BHST News Release--> BioHarvest Sciences Signs $1.2M CDMO Stage 2 Contract for the Development of a Rare Fragrance Using its Proprietary Botanical Synthesis Platform. View news release: https://ir.bioharvest.com/news/default.aspx The source plant is widely regarded as one of the most valuable fragrance raw materials in the world.

0 · Reply

newsfile_corp May. 12 at 11:31 AM

https://nfne.ws/297104 $BHST @BioHarvestBHSC #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals #NASDAQ #Investing

0 · Reply

forgottenchuck May. 11 at 11:59 PM

$BHST $CELH

1 · Reply

Market Cap	69.83M
Revenue (ttm)	34.51M
Net Income (ttm)	-11.14M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-32.28%
Debt to Equity Ratio	0.11

Volume	67,600
Avg Vol	31,708
Day's Range	N/A - N/A
Shares Out	19.62M
Stochastic %K	0%
Beta	0.70
Analysts	Strong Sell
Price Target	$12.75